Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Global Health Catalyst Summit Harvard /
Genomic trends across the African Diaspora for breast cancer

24th - 26th May 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.06.19
Views: 345

Prof Melissa B Davis - Weill Cornell Medical College, New York, USA

Prof Melissa Davis speaks to ecancer at the Global Health Catalyst Summit 2019 at the Dana Farber Cancer Institute in Boston, Massachusetts about her international breast cancer research across the African Diaspora.

She does this work in order to identify some of the genetic and molecular phenotypes which might explain some of the disparities we see in breast cancer mortality.

Prof Davis provides some examples of projects currently underway in Africa and America, and some of the emerging trends. She finishes by explaining why these kinds of genomic studies are important and lead the way to groundbreaking treatment options.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation